Clinical Trial Update: Selinexor Combined With BEAM for ASCT in R/R DLBCL With MYC Positive [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating selinexor in combination with BEAM conditioning for autologous stem cell transplantation in relapsed/refractory diffuse l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Selinexor (selinexor)

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING